[fcb5af]: / literature / by_gene / NFKB1.tsv

Download this file

# pmid doi year title Hugo_Symbol
1 35021606 10.3324/haematol.2021.280003 2022 Immune pathway upregulation and lower genomic instability distinguish EBV-positive nodal T/NK-cell lymphoma from ENKTL and PTCL-NOS. NFKB1
2 35089437 10.1007/s00018-022-04139-y 2022 A20 undermines alternative NF-κB activity and expression of anti-apoptotic genes in Helicobacter pylori infection. NFKB1
3 36009586 10.3390/biomedicines10082038 2022 Genomic Aberrations Generate Fusion Gene FOXK2::TP63 and Activate NFKB1 in Cutaneous T-Cell Lymphoma. NFKB1
4 33025009 10.1182/blood.2020004918 2021 MYD88 L265P elicits mutation-specific ubiquitination to drive NF-κB activation and lymphomagenesis. NFKB1
5 33684151 10.1371/journal.pone.0248259 2021 SNPs in genes encoding for IL-10, TNF-α, and NFκB p105/p50 are associated with clinical prognostic factors for patients with Hodgkin lymphoma. NFKB1
6 33707466 10.1038/s41598-021-84912-4 2021 CDK1 is up-regulated by temozolomide in an NF-κB dependent manner in glioblastoma. NFKB1
7 34364837 10.1016/j.cbi.2021.109619 2021 Anticancer effects of oleanolic acid on human melanoma cells. NFKB1
8 34401669 10.1016/j.isci.2021.102888 2021 Bisphenol A-induced DNA damages promote to lymphoma progression in human lymphoblastoid cells through aberrant CTNNB1 signaling pathway. NFKB1
9 31957805 10.1093/carcin/bgaa005 2020 Bcl-3 promotes multi-modal tumour cell migration via NF-κB1 mediated regulation of Cdc42. NFKB1
10 32452133 10.1111/jcmm.15383 2020 MALT1 is a potential therapeutic target in glioblastoma and plays a crucial role in EGFR-induced NF-κB activation. NFKB1
11 32712875 10.1007/s11064-020-03096-x 2020 miR-29c-3p Increases Cell Viability and Suppresses Apoptosis by Regulating the TNFAIP1/NF-κB Signaling Pathway via TNFAIP1 in Aβ-Treated Neuroblastoma Cells. NFKB1
12 32912211 10.1186/s12977-020-00538-w 2020 A novel positive feedback-loop between the HTLV-1 oncoprotein Tax and NF-κB activity in T-cells. NFKB1
13 33202260 10.1016/j.ajhg.2020.10.015 2020 Multiplexed Functional Assessment of Genetic Variants in CARD11. NFKB1
14 30696620 10.1182/blood-2018-08-871293 2019 Autocrine LTA signaling drives NF-κB and JAK-STAT activity and myeloid gene expression in Hodgkin lymphoma. NFKB1
15 30711173 10.1016/j.joen.2018.10.006 2019 Inhibition of Nuclear Factor Kappa B Prevents the Development of Experimental Periapical Lesions. NFKB1
16 30711250 10.1016/j.bbrc.2019.01.089 2019 NF-κB-dependent RANKL expression in a mouse model of immature T-cell leukemia. NFKB1
17 30787019 10.1182/bloodadvances.2018029322 2019 Cells of adult T-cell leukemia evade HTLV-1 Tax/NF-κB hyperactivation-induced senescence. NFKB1
18 30885361 10.1016/bs.acr.2019.01.004 2019 HVEM network signaling in cancer. NFKB1
19 30887112 10.1007/s00109-019-01777-x 2019 Activation of NF-κB in B cell receptor signaling through Bruton's tyrosine kinase-dependent phosphorylation of IκB-α. NFKB1
20 31344550 10.1016/j.virol.2019.07.011 2019 Association of polymorphisms in NFκB1 promoter and NFκBIA gene with the development of antibodies against HHV-8 in HIV-infected individuals. NFKB1
21 31497245 10.18632/oncotarget.27098 2019 Proliferative, pro-inflammatory, and angiogenesis regulator gene expression profile defines prognosis in different histopathological subtypes of nodal peripheral T-cell lymphoma. NFKB1
22 31574234 10.1096/fj.201900101RR 2019 Long intergenic noncoding RNA LINC00284 knockdown reduces angiogenesis in ovarian cancer cells <i>via</i> up-regulation of MEST through NF-κB1. NFKB1
23 31803180 10.3389/fimmu.2019.02618 2019 Late-Onset Antibody Deficiency Due to Monoallelic Alterations in <i>NFKB1</i>. NFKB1
24 29020881 10.1080/10245332.2017.1385194 2018 Knockdown of REGγ inhibits the proliferation and migration and promotes the apoptosis of multiple myeloma cells by downregulating NF-κB signal pathway. NFKB1
25 29449436 10.3324/haematol.2017.182048 2018 Mixed-species RNAseq analysis of human lymphoma cells adhering to mouse stromal cells identifies a core gene set that is also differentially expressed in the lymph node microenvironment of mantle cell lymphoma and chronic lymphocytic leukemia patients. NFKB1
26 29593668 10.3389/fmicb.2018.00380 2018 Simulation Study of cDNA Dataset to Investigate Possible Association of Differentially Expressed Genes of Human THP1-Monocytic Cells in Cancer Progression Affected by Bacterial Shiga Toxins. NFKB1
27 29698475 10.1371/journal.ppat.1006968 2018 CADM1 is essential for KSHV-encoded vGPCR-and vFLIP-mediated chronic NF-κB activation. NFKB1
28 29976660 10.1128/JVI.00580-18 2018 Upregulation of MicroRNA 711 Mediates HIV-1 Vpr Promotion of Kaposi's Sarcoma-Associated Herpesvirus Latency and Induction of Pro-proliferation and Pro-survival Cytokines by Targeting the Notch/NF-κB-Signaling Axis. NFKB1
29 30116272 10.1186/s11658-018-0102-4 2018 The notch pathway promotes NF-κB activation through Asb2 in T cell acute lymphoblastic leukemia cells. NFKB1
30 30127896 10.3892/ol.2018.9010 2018 Burkitt lymphoma-associated network construction and important network motif analysis. NFKB1
31 27840321 10.1016/j.freeradbiomed.2016.11.010 2017 Pro-apoptotic effects of lipid oxidation products: HNE at the crossroads of NF-κB pathway and anti-apoptotic Bcl-2. NFKB1
32 28152513 10.18632/oncotarget.14934 2017 Propiece IL-1α facilitates the growth of acute T-lymphocytic leukemia cells through the activation of NF-κB and SP1. NFKB1
33 28232371 10.3324/haematol.2016.156281 2017 c-Myc dysregulation is a co-transforming event for nuclear factor-κB activated B cells. NFKB1
34 28281555 10.1038/modpathol.2017.5 2017 NF-κB p50 activation associated with immune dysregulation confers poorer survival for diffuse large B-cell lymphoma patients with wild-type p53. NFKB1
35 28346502 10.1371/journal.pone.0174136 2017 EBV induces persistent NF-κB activation and contributes to survival of EBV-positive neoplastic T- or NK-cells. NFKB1
36 28368397 10.1038/onc.2017.90 2017 Molecular impact of selective NFKB1 and NFKB2 signaling on DLBCL phenotype. NFKB1
37 28369050 10.1038/ni.3716 2017 Antagonism of B cell enhancer networks by STAT5 drives leukemia and poor patient survival. NFKB1
38 28672935 10.3892/etm.2017.4464 2017 Next-generation sequencing reveals lymph node metastasis associated genetic markers in colorectal cancer. NFKB1
39 28684863 10.1038/emm.2017.89 2017 Bcl3: a regulator of NF-κB inducible by TWEAK in acute kidney injury with anti-inflammatory and antiapoptotic properties in tubular cells. NFKB1
40 28689659 10.1016/j.molcel.2017.06.011 2017 Bcl3 Phosphorylation by Akt, Erk2, and IKK Is Required for Its Transcriptional Activity. NFKB1
41 29333957 10.1177/1533034617745761 2017 MiR-98 Promotes Apoptosis of Glioma Cells via Suppressing IKBKE/NF-κB Pathway. NFKB1
42 25912249 10.4274/tjh.2014.0190 2016 Deregulated Levels of the NF-κB1, NF-κB2, and Rel Genes in Ukrainian Patients with Leukemia and Lymphoma in the Post-Chernobyl Period. NFKB1
43 26275874 10.1007/82_2015_479 2016 Roles of the NF-κB Pathway in B-Lymphocyte Biology. NFKB1
44 26526716 10.1053/j.gastro.2015.10.017 2016 BCL3 Reduces the Sterile Inflammatory Response in Pancreatic and Biliary Tissues. NFKB1
45 26573110 10.3892/ijo.2015.3238 2016 Involvement of cyclic-nucleotide response element-binding family members in the radiation response of Ramos B lymphoma cells. NFKB1
46 26648441 10.3892/mmr.2015.4606 2016 Effects of miR‑590 on oxLDL‑induced endothelial cell apoptosis: Roles of p53 and NF‑κB. NFKB1
47 26767426 10.1016/j.jid.2015.12.027 2016 MALT1 Protease Activity Controls the Expression of Inflammatory Genes in Keratinocytes upon Zymosan Stimulation. NFKB1
48 26776161 10.1038/onc.2015.493 2016 Oncogenic CARMA1 couples NF-κB and β-catenin signaling in diffuse large B-cell lymphomas. NFKB1
49 26792751 10.1128/JVI.03000-15 2016 The Major Histocompatibility Complex Class II Transactivator CIITA Inhibits the Persistent Activation of NF-κB by the Human T Cell Lymphotropic Virus Type 1 Tax-1 Oncoprotein. NFKB1
50 27221964 10.1016/j.semcancer.2016.05.001 2016 NF-κB deregulation in Hodgkin lymphoma. NFKB1
51 27262792 10.1016/j.semcancer.2016.05.002 2016 Mechanisms of NF-κB deregulation in lymphoid malignancies. NFKB1
52 27338827 10.1007/s10875-016-0306-1 2016 NF-κB1 Haploinsufficiency Causing Immunodeficiency and EBV-Driven Lymphoproliferation. NFKB1
53 27402288 10.1016/j.semcancer.2016.07.001 2016 Toll-like receptors signaling: A complex network for NF-κB activation in B-cell lymphoid malignancies. NFKB1
54 27440900 10.1128/JVI.00797-16 2016 HIV-1 Vpr Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication by Inducing MicroRNA miR-942-5p and Activating NF-κB Signaling. NFKB1
55 27452667 10.1016/j.semcancer.2016.07.003 2016 MALT lymphoma: A paradigm of NF-κB dysregulation. NFKB1
56 27488529 10.1158/0008-5472.CAN-16-0595 2016 TG2 and NF-κB Signaling Coordinates the Survival of Mantle Cell Lymphoma Cells via IL6-Mediated Autophagy. NFKB1
57 27489104 10.1074/jbc.M116.719302 2016 The Nuclear Protein IκBζ Forms a Transcriptionally Active Complex with Nuclear Factor-κB (NF-κB) p50 and the Lcn2 Promoter via the N- and C-terminal Ankyrin Repeat Motifs. NFKB1
58 27503810 10.1016/j.semcancer.2016.08.002 2016 NF-κB deregulation in splenic marginal zone lymphoma. NFKB1
59 27546290 10.1016/j.semcancer.2016.08.001 2016 Genetic drivers of NF-κB deregulation in diffuse large B-cell lymphoma. NFKB1
60 28028966 10.17219/acem/63752 2016 Glycogen Synthase Kinase-3β (GSK-3β) and Nuclear Factor Kappa-B (NFKB) in Childhood Acute Lymphoblastic Leukemia. NFKB1
61 25394713 10.1038/leu.2014.324 2015 GAPDH enhances the aggressiveness and the vascularization of non-Hodgkin's B lymphomas via NF-κB-dependent induction of HIF-1α. NFKB1
62 25541152 10.1038/leu.2014.351 2015 MicroRNAs in B-cell lymphomas: how a complex biology gets more complex. NFKB1
63 25572145 10.1042/BSR20140160 2015 Re-expression of HPV16 E2 in SiHa (human cervical cancer) cells potentiates NF-κB activation induced by TNF-α concurrently increasing senescence and survival. NFKB1
64 25636172 10.1016/j.humpath.2014.06.032 2015 Clinicopathological implications of nuclear factor κB signal pathway activation in diffuse large B-cell lymphoma. NFKB1
65 25837675 10.1158/1535-7163.MCT-14-1053 2015 MAP17 (PDZKIP1) Expression Determines Sensitivity to the Proteasomal Inhibitor Bortezomib by Preventing Cytoprotective Autophagy and NFκB Activation in Breast Cancer. NFKB1
66 25922067 10.1074/jbc.M115.643700 2015 Mapping the Interaction of B Cell Leukemia 3 (BCL-3) and Nuclear Factor κB (NF-κB) p50 Identifies a BCL-3-mimetic Anti-inflammatory Peptide. NFKB1
67 25951043 10.1080/15548627.2015.1017192 2015 The role of STAT3 in autophagy. NFKB1
68 25960206 10.1002/gcc.22253 2015 NFkB is activated by multiple mechanisms in hairy cell leukemia. NFKB1
69 25987724 10.1084/jem.20142009 2015 Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia. NFKB1
70 25996250 10.1111/febs.13325 2015 MALT1--a universal soldier: multiple strategies to ensure NF-κB activation and target gene expression. NFKB1
71 26043790 10.1080/15548627.2015.1052205 2015 Cocaine-mediated microglial activation involves the ER stress-autophagy axis. NFKB1
72 26049760 10.1097/MOH.0000000000000160 2015 Unexpected functions of nuclear factor-κB during germinal center B-cell development: implications for lymphomagenesis. NFKB1
73 26060405 10.2147/OTT.S82936 2015 Oral treatment with the herbal formula B307 alleviates cardiac toxicity in doxorubicin-treated mice via suppressing oxidative stress, inflammation, and apoptosis. NFKB1
74 26112410 10.1074/jbc.M114.630061 2015 The Transitional Endoplasmic Reticulum ATPase p97 Regulates the Alternative Nuclear Factor NF-κB Signaling via Partial Degradation of the NF-κB Subunit p100. NFKB1
75 26391888 10.1038/srep14315 2015 Genome-wide homozygosity signature and risk of Hodgkin lymphoma. NFKB1
76 26477771 10.3760/cma.j.issn.0253-2727.2015.10.016 2015 [Clinical significance of NF-κB/p65 expression in patients with diffuse large B-cell lymphoma]. NFKB1
77 26487345 10.1038/srep15215 2015 Transcription factor and miRNA co-regulatory network reveals shared and specific regulators in the development of B cell and T cell. NFKB1
78 26606782 2015 [PROGNOSTIC ROLE OF NF-κB EXPRESSION IN DIFFUSE LARGE B-CELL LYMPHOMA SUBGROUPS]. NFKB1
79 26612043 10.1007/s11427-015-4977-2 2015 Molecular pathogenesis of lymphomas of mucosa-associated lymphoid tissue--from (auto)antigen driven selection to the activation of NF-κB signaling. NFKB1
80 26668357 10.1073/pnas.1507459112 2015 Lymphomagenic CARD11/BCL10/MALT1 signaling drives malignant B-cell proliferation via cooperative NF-κB and JNK activation. NFKB1
81 27308399 10.4161/23723548.2014.968073 2015 Nfkb1 suppresses DNA alkylation-induced tumor formation. NFKB1
82 23886693 10.1016/j.imbio.2013.06.013 2014 Activation of NF-κB and respiratory burst following Aspergillus fumigatus stimulation of macrophages. NFKB1
83 24200242 10.1089/scd.2013.0270 2014 Resistance of hematopoietic progenitors to Fas-mediated apoptosis is actively sustained by NFκB with a characteristic transcriptional signature. NFKB1
84 24292677 10.1038/onc.2013.503 2014 YGLF motif in the Kaposi sarcoma herpes virus G-protein-coupled receptor adjusts NF-κB activation and paracrine actions. NFKB1
85 24296945 10.1038/leu.2013.365 2014 Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation. NFKB1
86 24393203 10.1186/1476-4598-13-5 2014 NF-kappa B mediated up-regulation of CCCTC-binding factor in pediatric acute lymphoblastic leukemia. NFKB1
87 24419302 10.1007/s00018-013-1545-4 2014 NF-κB pathways in hematological malignancies. NFKB1
88 24459141 10.1074/jbc.M114.551986 2014 Inhibition of transcription by B cell Leukemia 3 (Bcl-3) protein requires interaction with nuclear factor κB (NF-κB) p50. NFKB1
89 24548923 10.1016/j.molimm.2014.01.011 2014 Phosphorylation of Carma1, but not Bcl10, by Akt regulates TCR/CD28-mediated NF-κB induction and cytokine production. NFKB1
90 24704296 10.1016/j.canlet.2014.03.030 2014 The NF-κB inhibitor DHMEQ decreases survival factors, overcomes the protective activity of microenvironment and synergizes with chemotherapy agents in classical Hodgkin lymphoma. NFKB1
91 24867094 10.1007/s13277-014-1998-6 2014 Crebanine, an aporphine alkaloid, sensitizes TNF-α-induced apoptosis and suppressed invasion of human lung adenocarcinoma cells A549 by blocking NF-κB-regulated gene products. NFKB1
92 24971370 10.1155/2014/492872 2014 Alternative expression pattern of MALT1-A20-NF-κB in patients with rheumatoid arthritis. NFKB1
93 23328932 10.1007/s00428-013-1372-x 2013 Nuclear factor-κB activation in primary lymphoma of bone. NFKB1
94 23360303 10.1111/bjh.12206 2013 The Bruton tyrosine kinase (BTK) inhibitor PCI-32765 synergistically increases proteasome inhibitor activity in diffuse large-B cell lymphoma (DLBCL) and mantle cell lymphoma (MCL) cells sensitive or resistant to bortezomib. NFKB1
95 23441730 10.1042/BJ20121651 2013 The anti-inflammatory drug BAY 11-7082 suppresses the MyD88-dependent signalling network by targeting the ubiquitin system. NFKB1
96 23603894 10.1254/jphs.12149fp 2013 Inhibition of the PI3K/AKT-NF-κB pathway with curcumin enhanced radiation-induced apoptosis in human Burkitt's lymphoma. NFKB1
97 23752607 10.5604/17322693.1052449 2013 Expression of PIM-2 and NF-κB genes is increased in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) and is associated with complete remission rate and overall survival. NFKB1
98 23821202 10.1167/iovs.13-12272 2013 MicroRNA profiling in ocular adnexal lymphoma: a role for MYC and NFKB1 mediated dysregulation of microRNA expression in aggressive disease. NFKB1
99 23868181 10.1002/path.4239 2013 Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma. NFKB1
100 23869088 10.1182/blood-2013-06-508028 2013 IκB-ζ controls the constitutive NF-κB target gene network and survival of ABC DLBCL. NFKB1